BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3407193)

  • 1. Recent results of reoperative surgery in medullary carcinoma of the thyroid.
    Tisell LE; Jansson S
    Wien Klin Wochenschr; 1988 May; 100(11):347-8. PubMed ID: 3407193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reintervention in C-cell carcinoma].
    Wahl RA; Goretzki PE; Branscheid D; Vietmeier P; Röher HD
    Wien Klin Wochenschr; 1988 May; 100(11):348-51. PubMed ID: 2900580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullary thyroid carcinoma: surgical management of primary tumor and locoregional recurrence.
    Bellantone R; Boscherini M; Lombardi CP; Alesina PF
    Rays; 2000; 25(2):267-71. PubMed ID: 11370544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma.
    Tisell LE; Hansson G; Jansson S; Salander H
    Surgery; 1986 Jan; 99(1):60-6. PubMed ID: 3942001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Repeat surgery for recurrent thyroid cancer in children].
    Demidchik IuE; Kontratovich VA
    Vopr Onkol; 2003; 49(3):366-9. PubMed ID: 12926223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical results of reoperations for medullary thyroid carcinoma.
    Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
    Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland].
    Krassowski J; Słowińska-Srzednicka J; Gietka M; Sawicki A; Kokot F; Zgliczyński S
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):757-9. PubMed ID: 2641802
    [No Abstract]   [Full Text] [Related]  

  • 9. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
    Horn J; Pfarr B; Ziegler R
    Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
    Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS
    Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review analysis of medullary carcinoma of the thyroid: a 15-year Indian experience.
    Dorairajan N; Siddharth D; Kanna S
    Int Surg; 2006; 91(3):162-7. PubMed ID: 16845858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer.
    Kupferman ME; Mandel SJ; DiDonato L; Wolf P; Weber RS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1209-12. PubMed ID: 12169901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medullary carcinoma of the thyroid: a clinical contribution].
    Angeli G; Brazzarola P; Bottura D; Bonomo S; Castellini C; Moser A; Vicenzi L; Mazzola F; Rizzo S; Betresini B; Ballarin A; Rosa G
    Chir Ital; 2002; 54(1):25-9. PubMed ID: 11942005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative pentagastrin-stimulated serum calcitonin concentrations in patients with medullary thyroid carcinoma: reoperations in patients with concentrations bordering the detection limit.
    Meybier H; Schmidt-Gayk H; Buhr H; Raue F
    Henry Ford Hosp Med J; 1989; 37(3-4):138-40. PubMed ID: 2576947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
    Kim ES; Kim TY; Koh JM; Kim YI; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):145-8. PubMed ID: 15212657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of nodal metastasis for primary and reoperative thyroid cancer.
    Machens A; Hinze R; Thomusch O; Dralle H
    World J Surg; 2002 Jan; 26(1):22-8. PubMed ID: 11898029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD; Moley JF
    Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.